Supriya Lifescience Limited has informed that the European Directorate for the Quality of Medicines (EDQM) has granted Attestation of Inspection (EU-GMP) for Lote API Facility, Ratnagiri, Maharashtra.
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
EC grants conditional marketing authorization based on the EFFISAYIL trial
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
The award recognizes Parexel for delivering the best decentralized trial experience for customers through its capabilities, expertise, and patient recruitment and retention strategies
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India
Subscribe To Our Newsletter & Stay Updated
